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INTRODUCTION
Among the neonatal seizure syndromes, benign familial
neonatal convulsions (BFNC), a rare autosomal dominant
epilepsy characterized by unprovoked, generalized convul-
sions occurring in the first days of life, must be differentiat-
ed from non-epileptic paroxysmal events of the newborn and
from other etiologies of neonatal seizures. The seizures are
characterized by generalized hypertonia with apnea and cya-
nosis, followed by head movement and/or clonic or tonic-
clonic limb jerks (1). Most patients are seizure-free by 6 mon-
ths of age, and psychomotor development in affected chil-
dren is usually normal (2). Although BFNC represent a ben-
ign epilepsy syndrome, between 10% and 16% of patients
experience seizure recurrence at a later time (1).
The idiopathic epilepsies, among which BFNC was listed,
have been regarded as genetic in origin. This presumption
was confirmed by the identification of mutations in KCNQ2
and KCNQ3 in families with BFNC. 
We report here the first Korean family with BFNC. Five
individuals in 3 generations were affected, and molecular
analysis disclosed a KCNQ2 mutation.
CASE REPORT
Index case (IIId)
A female infant weighing 2.8 kg was born at 39 weeks, 2
days gestation to a 28-yr-old mother after an uncomplicated
pregnancy. On the 3rd day of life, she presented with three
brief generalized tonic seizures with upward deviation of the
eyes and cyanosis of the lips which lasted approximately one
minute. General and neurologic examinations were unre-
markable. Electrolytes, calcium, glucose, cerebrospinal fluid
examination, brain magnetic resonance imaging and electroen-
cephalography (EEG) were all normal. She was discharged
after 3 days without further seizures on phenobarbital. In fol-
low-up, her phenobarbital was weaned at 3 months of age,
but her seizures recurred 1 month later. Her EEG showed
several spike discharges originating from the left and right
central-temporal areas at that time. Phenobarbital was restart-
ed and tapered off successfully without any seizure recurrence
at 7 months of age. The child has had a normal neurodevel-
opmental course thereafter.
Detailed review of her family history revealed five affected
family members, in three separate generations, who experi-
enced similar neonatal convulsions, including the patient’s
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The First Korean Case of KCNQ2 Mutation in a Family with Benign
Familial Neonatal Convulsions
Neonatal seizures represent a heterogeneous group of disorders with vastly differ-
ent etiologies and outcomes. Benign familial neonatal convulsions (BFNC) are a
distinctive epileptic syndrome of autosomal dominant inheritance with a favorable
prognosis, characterized by the occurrence of unprovoked partial or generalized
clonic seizures in the neonatal period or early infancy. Recently, mutations in two
potassium channel genes, KCNQ2 and KCNQ3, have been described in this dis-
order. In this report, we describe a family with BFNC due to a KCNQ2 mutation, the
first such family to be described in the Korean population. The diagnosis of BFNC
can be made based on clinical suspicion and careful history taking with special
emphasis on the familial nature of the disorder. KCNQ2 mutations may be associ-
ated with BFNC in a number of different races, as has been reported in other eth-
nic groups.
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grandfather, father, paternal uncle, and cousin (Fig. 1).
Patients
Ia (Grandfather): Patient Ia had 3 convulsions within the
1st month of life, but no further seizures after those initial
episodes. 
IIc (Paternal uncle): This patient experienced 5 convulsions
within the first 3 months of his life. No further seizures were
noted thereafter. The patient graduated from a postgraduate
school.
IIe (Father): He experienced a single convulsion on the 2nd
day of life. He also graduated from a postgraduate school and
has no neurologic problems. 
IIIc (A cousin): Eight months-old at the time of this writ-
ing. Although he experienced 6 convulsions within the 6
months of life, he has shown normal development. 
In sum, despite multiple infantile seizures, no epilepsy or
psychomotor dysfunction occurred in any affected family
members even without the use of antiepileptic drugs. 
To search for mutations in KCNQ2 in the pedigree, 16
exons and adjacent short intronic sequences of the gene were
amplified by polymerase chain reaction (PCR) with DNA
obtained from the affected individuals. Sixteen exons of the
KCNQ2 gene and their intronic flanking sequences were
amplified by PCR using a total of 19 sets of primers with
exon 1 split into two and exon 6 into three primer pairs. 
Genetic study revealed an R448X mutation located in the
C-terminal segment of KCNQ2 in the family members with
neonatal seizures (Ia, IIe, IIId, Fig. 2).
DISCUSSION
BFNC remains a diagnosis of exclusion, since many neo-
nates present with cryptogenic convulsions associated with
uncertain outcomes. Symptomatic neonatal seizures, secon-
dary to hypoxic-ischemic-encephalopathy, metabolic distur-
bances or to an infectious process should be ruled out. Sub-
sequently, the finding of self-limited neonatal seizures in mul-
tiple affected family members can clinch the diagnosis. 
BFNC may be caused by mutations in KCNQ2 or KCN-
Q3. The KCNQ2 and KCNQ3 genes encode the heteromer-
ic assembly of subunits through which muscarinic-regulat-
ed potassium current (M-current), a primary regulator of
neuronal excitability, is established (3). The functional anal-
ysis of mutations thus far has indicated that a partial loss of
activity of the K+ current is sufficient to produce epilepsy,
and dominant negative mutations in KCNQ2 or KCNQ3
can result in a more severe phenotype (4). 
In our case, the family history given by the grandmother
of the proband was key to the diagnosis, and further genetic
study identified a putative causative mutation in KCNQ2,
the R448X (5, 6). Consistent with prior cases of R448X (5),
none of our patients have experienced seizures outside of in-
fancy. Interestingly, the KCNQ2 C-terminal truncation mu-
tant R448X has been shown to reduce the potassium current
by <50% and to cause no changes in the ion channel’s bio-
physical properties (6). Given recent findings that ion chan-
nels may regulate diverse cellular functions in addition to
their current conduction properties, this finding may sug-
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Fig. 1. The pedigree of the patients. Open symbols indicate healthy
individuals and solid black symbols indicate affected individuals.
An arrow indicates the index case.
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Fig. 2. DNA analysis of the involved patients. To search for mutations in KCNQ2 in the pedigree, 16 exons and adjacent short intronic se-
quences of the gene were amplified by polymerase chain reaction with DNA obtained from the affected individuals. Genetic study revealed
a c.1342C>T (p. Arg448X) mutation located in the C-terminal segment of KCNQ2 in the family members with neonatal seizures (Ia, IIe, IIId).326 M.-S. Yum, T.-S. Ko, and H.-W. Yoo
gest that another property of the KCNQ2 may be involved
in its epileptogenic properties.
BFNC is an age-dependent, genetically determined epilep-
sy that typically resolves spontaneously. Kanaumi et al. (7)
have demonstrated simultaneous high expression of KCNQ2
and KCNQ3 in human brain from late fetal life through in-
fancy, coinciding with the time that BFNC occurs. Such de-
velopmental changes in potassium channel activity in the
developing brain may explain the age-dependent expression
of BFNC. However, inter-familial differences in susceptibil-
ity to subsequent febrile or afebrile seizures (1, 8) have been
observed, and further genotype-phenotype correlations may
facilitate our understanding of this condition.
Due to the immaturity of neonatal brain structures, ana-
lyzing the ictal phenomenology and EEG and definitive clas-
sification of BFNC is still difficult. On the other hand, BF-
NC shares features with benign rolandic epilepsy, the most
common idiopathic localization-related epilepsy, including
its age-dependency and presence of centrotemporal spikes (9,
10). In our study, the index case showed intermittent right
or left centrotemporal sharp wave discharges, and the seizures
observed were generalized tonic seizures. It is thought that
as data accumulates, the electroclinical features of the ictal,
interictal and follow-up EEG may yield insight into the me-
chanism of seizure generation. 
In conclusion, we report the first Korean case of BFNC with
genetic confirmation. The mutation was the same KCNQ2
as has been reported in other ethnic groups.
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